The Amazing son in law Chapter 1469

Jiro Kobayashi was taken aback by Liam’s straightforward refusal.

Shouldn’t there be some consideration or at least a show of deliberation in business negotiations? This seemed like a basic principle of respect.

Despite his frustration, Jiro Kobayashi chose to keep his composure.

With a polite smile, he addressed Liam: “Manager Weaver, I hope you don’t mind me being frank. While Oracle Pharmaceuticals may have its merits, it doesn’t stand out as a leading pharmaceutical company in China, and it’s even less prominent on the global stage. If your goal is to expand into the Asian market or beyond, your current capabilities make it unlikely that you’ll achieve meaningful breakthroughs.”

He then proudly patted his chest and continued, “In contrast, Kobayashi Pharmaceuticals boasts a rich history spanning several decades, and we’ve already established a significant presence in international markets. Our overall strength surpasses yours; our production lines are more advanced, and our production capacity is far superior. Given these advantages, why not consider a deeper collaboration with Kobayashi Pharmaceuticals?”

Liam responded with a hint of sarcasm, saying, “Mr. Kobayashi, it’s true that Oracle Pharmaceuticals isn’t as large as your company, but I firmly believe that with the exceptional effectiveness of our products, we can achieve rapid growth through word-of-mouth alone. We can easily reach global markets, and even without overseas expansion, international consumers will seek out our offerings. That’s the power of quality products.”

Jiro Kobayashi’s expression soured slightly as he acknowledged the truth in Liam’s words.

He was aware of how impressive Nova Dias was. Read complete version only at fіndnovel.net

Last night, out of curiosity, he tried a pack of Nova Dias. To his surprise, it completely alleviated his stomach discomfort without any signs of recurrence.

Its effectiveness and longevity far surpassed that of Kobayashi’s stomach powder.

If this trend continued, once Oracle’s Nova Dias was officially launched, Kobayashi’s version could face severe market competition.

There’s a universal truth in the marketplace: when a product excels, it often sparks organic user promotion, leading to rapid viral growth.

After all, word-of-mouth can be more powerful than any advertisement.

Thus, he suppressed his anger and maintained a cordial demeanor, saying to Liam, “Manager Weaver, I truly recognize the quality of your products. However, I must admit that there remains a substantial gap in productivity and production processes between our companies.”

“Moreover, attempting to scale up production in a short timeframe can be quite challenging. You’ll need to find a suitable location for expansion, construct a factory, and introduce new production lines. This process typically spans one to two years, which means you won’t be able to seize the market quickly due to limited production capacity.”

“If you were open to collaborating with Kobayashi Pharmaceuticals, we could significantly help bridge those gaps. Together, we could create a profitable partnership!”

“In that scenario, I could allocate all Kobayashi’s production lines to Oracle Nova Dias. We could establish a cooperative ratio—say, you receive 60%, and I take 40%. We could even rebrand Oracle Nova Dias as Kobayashi Nova Dias, symbolizing a partnership between Oracle Pharmaceuticals and Kobayashi Pharmaceuticals!”

“Keep in mind that Kobayashi Pharmaceuticals boasts productivity levels that are at least eight to ten times greater than Oracle’s. We have multiple production lines in Japan and three additional lines in China and Southeast Asia, all equipped with top-tier technology. Building equivalent production lines would take you a minimum of five to eight years. So, why not consider a partnership with us?”

Jiro Kobayashi presented his case passionately. All Liam could think about was how Oracle Pharmaceuticals needed to bolster its production capabilities.